コンテンツへスキップ
Merck

HNS1MAG-95K

Millipore

MILLIPLEX® Human Neuroscience Magnetic Bead Panel 1 - Neuroscience Multiplex Assay

allows quantitative multiplex detection of multiple analytes simultaneously

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12161503
eCl@ss:
32161000
NACRES:
NA.47

To order a Milliplex® kit, please search for your analyte of interest.

品質水準

交差性

human

メーカー/製品名

Milliplex®

assay range

accuracy: 107%
(DJ1)

accuracy: 108%
(a-Synuclein)

accuracy: 123%
(TG2)

standard curve range: 12-50,000 pg/mL
(GFAP)

standard curve range: 15-60,000 pg/mL
(NSE)

standard curve range: 20-80,000 pg/mL
(UCHL1)

standard curve range: 244-1,000,000 pg/mL
(alpha-synuclein)

standard curve range: 61-250,000 pg/mL
(DJ1)

standard curve range: 61-250,000 pg/mL
(TG2)

テクニック

multiplexing: suitable

検出方法

fluorometric (Luminex xMAP)

輸送温度

ambient

詳細

Neurological dysfunction may be initiated by a broad spectrum of diseases, as well as physical injury to the brain or spinal cord. Numerous potential biomarkers of neurological dysfunction have been identified. The ability to perform multiplex analysis of these biomarkers offers a valuable research tool to better understand this area of neuroscience.

MILLIPLEX® Human Neuroscience Bead Panel 1 is a 6-plex kit to be used for the simultaneous quantification of any or all of the following analytes in cerebrospinal fluid (CSF) samples: α-Synuclein, DJ1/PARK7, Glial fibrillary acidic protein (GFAP), Neuron specific enolase (NSE), Transglutaminase 2 (TGM2), and Ubiquitin carboxyl-terminal esterase L1 (UCHL1/PARK5).

Panel Type: Neuroscience

特異性

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

アプリケーション

  • Analytes: GFAP, NSE, α-Synuclein, PARK5, Transglutaminase 2 (TGM2)
  • Recommended Sample type: CSF
  • Recommended Sample dilution: Neat
  • Assay Run Time: Overnight or one day
  • Research Category: Neuroscience

特徴および利点

Design your multiplex kit by choosing available analytes within this panel.

包装

Everything you need in a single kit.

保管および安定性

Recommended storage for kit components is 2 - 8°C.

その他情報

Sensitivity: See protocol for sensitivities of individual analytes

法的情報

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Daniela Diaz-Lucena et al.
Journal of neurology, 267(9), 2567-2581 (2020-05-07)
Differential diagnosis of neurodegenerative dementia is currently supported by biomarkers including cerebrospinal fluid (CSF) tests. Among them, CSF total-tau (t-tau), phosphorylated tau (p-tau) and β-amyloid42 (Aβ42) are considered core biomarkers of neurodegeneration. In the present work, we hypothesize that simultaneous
Martin Trapecar et al.
Science advances, 7(5) (2021-01-31)
Slow progress in the fight against neurodegenerative diseases (NDs) motivates an urgent need for highly controlled in vitro systems to investigate organ-organ- and organ-immune-specific interactions relevant for disease pathophysiology. Of particular interest is the gut/microbiome-liver-brain axis for parsing out how

関連コンテンツ

Learn how to integrate multiplex and high sensitivity immunoassay technology to further neuroscience research with MILLIPLEX® multiplex and Single Molecule Counting (SMC®) high sensitivity immunoassay detection of Alzheimer’s disease (AD) biomarkers in human cerebrospinal fluid, plasma, and serum samples.

MILLIPLEX®マルチプレックスと1分子カウント(Single Molecule Counting、SMC®)高感度イムノアッセイ技術を組み合わせて、ヒト脳脊髄液、血漿、および血清サンプル中のアルツハイマー病(AD)バイオマーカーを検出し、神経科学研究を推進する方法を紹介します。

MILLIPLEX®マルチプレックスアッセイなどの神経科学マルチプレックスアッセイにより、神経科学関連のバイオマーカーを同時に測定することで、神経変性疾患、神経障害、および神経ペプチド/神経ホルモンシグナル伝達の全体像をより正確に把握できるようになります。

Learn how multiplex detection of Alzheimer’s disease biomarkers, using the MILLIPLEX® Human Amyloid Beta and Tau Magnetic Bead Panel, allows for a different perspective on neurodegenerative disease research.

すべて表示

質問

1–2/2 質問  
  1. How can I normalize protein for this test? Just using same volume and total concentration protein are not reliable.

    1 回答
    1. The kit has been verified for use with CSF and cell/tissue culture supernatants. Protein normalization is not required for these sample types. If using the kit with cell or tissue lysates, the sample will need to be normalized to total protein, using either a BCA or Coomassie-based assay. The product has not been validated for use with cell/tissue lysates.

      役に立ちましたか?

  2. Can serum or plasma samples be utilized in the Human Neuroscience Panel 1 kit, considering that the protocol exclusively mentions CSF?

    1 回答
    1. The kit has not been validated with serum/plasma samples. Eight normal plasma samples were tested at a 1:4 dilution. It was found that GFAP and UCHL1 will require more sensitivity.

      役に立ちましたか?

レビュー

評価値なし

アクティブなフィルタ

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)